New Haven, CT — September 2, 2025 — Leads & Copy — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), has terminated its ATM (At-The-Market) instrument with investment bank Alliance Global Partners (AGP).
According to Ilan Danieli, Precipio’s CEO, the company is in a stronger position today than when it entered into this structure. The elimination of negative cash flow from operations, and recent increases of the company’s cash balance give them confidence that they no longer have to rely on tools like this for capital raises.
Danieli added that management is committed to creating shareholder value, and this termination is one more step in that direction.
Contact: investors@precipiodx.com +1-203-787-7888 Ext. 523
Source: Precipio
